BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 8590859)

  • 1. The physiologic role and therapeutic potential of the Mpl-ligand in thrombopoiesis.
    Hunt P
    Stem Cells; 1995 Nov; 13(6):579-87. PubMed ID: 8590859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biology of thrombopoietin and its receptors].
    Robak T
    Postepy Hig Med Dosw; 1996; 50(6):649-63. PubMed ID: 9064684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombopoietin: biology and clinical potentials.
    Miyazaki H; Kato T
    Int J Hematol; 1999 Dec; 70(4):216-25. PubMed ID: 10643146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structure, biology and potential therapeutic applications of recombinant thrombopoietin.
    Lok S; Foster DC
    Stem Cells; 1994 Nov; 12(6):586-98. PubMed ID: 7881359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Megakaryocyte development and platelet production.
    Deutsch VR; Tomer A
    Br J Haematol; 2006 Sep; 134(5):453-66. PubMed ID: 16856888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Regulation of megakaryopoiesis and thrombopoiesis by thrombopoietin].
    Oda A; Ikeda Y
    Rinsho Byori; 1998 May; 46(5):430-4. PubMed ID: 9627493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombopoietin: the primary regulator of megakaryocyte and platelet production.
    Kaushansky K
    Thromb Haemost; 1995 Jul; 74(1):521-5. PubMed ID: 8578518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thrombopoietic growth factor--thrombopoietin. Molecular and biological properties].
    Skotnicki AB; Jabłoński MJ
    Przegl Lek; 1996; 53(11):826-9. PubMed ID: 9173448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical use of thrombopoietin (c-Mpl Ligand)].
    Borota R; Borota J; Belić A; Gebauer E; Stefanović N
    Med Pregl; 1998; 51(11-12):501-8. PubMed ID: 10081270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombopoietin and megakaryocyte differentiation].
    Vainchenker W; Debili N; Norol F; Wendling F
    Schweiz Med Wochenschr; 1998 Oct; 128(42):1575-81. PubMed ID: 9824885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Mpl ligands on platelet production and function in nonhuman primates.
    Harker LA; Marzec UM; Kelly AB
    Stem Cells; 1998; 16 Suppl 2():107-19. PubMed ID: 11012183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombopoietin (Mpl ligand) and the regulation of platelet production.
    Cohen-Solal K; Debili N; Vainchenker W; Wendling F
    Eur Cytokine Netw; 1997 Sep; 8(3):311-4. PubMed ID: 9346371
    [No Abstract]   [Full Text] [Related]  

  • 13. Megakaryocyte growth and development factor (MGDF): an Mpl ligand and cytokine that regulates thrombopoiesis.
    Neumann TA; Foote M
    Cytokines Cell Mol Ther; 2000 Mar; 6(1):47-56. PubMed ID: 10976539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic deficiencies in c-mpl and TPO knockout mice.
    Murone M; Carpenter DA; de Sauvage FJ
    Stem Cells; 1998; 16(1):1-6. PubMed ID: 9474742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of platelet growth factors in cancer therapy.
    Clarke K; Basser RL
    Stem Cells; 1996; 14 Suppl 1():274-80. PubMed ID: 11012231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis.
    Nogami W; Yoshida H; Koizumi K; Yamada H; Abe K; Arimura A; Yamane N; Takahashi K; Yamane A; Oda A; Tanaka Y; Takemoto H; Ohnishi Y; Ikeda Y; Miyakawa Y
    Haematologica; 2008 Oct; 93(10):1495-504. PubMed ID: 18728031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombopoietin: its role from early hematopoiesis to platelet production.
    Wendling F
    Haematologica; 1999 Feb; 84(2):158-66. PubMed ID: 10091415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
    Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
    Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine production and function in c-mpl-deficient mice: no physiologic role for interleukin-3 in residual megakaryocyte and platelet production.
    Gainsford T; Roberts AW; Kimura S; Metcalf D; Dranoff G; Mulligan RC; Begley CG; Robb L; Alexander WS
    Blood; 1998 Apr; 91(8):2745-52. PubMed ID: 9531584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relative population sizes of megakaryocytic cells in mouse bone marrow as determined by mpl ligand responsiveness.
    Mintern J; Williams N; Jackson H
    Exp Hematol; 1997 Nov; 25(12):1233-9. PubMed ID: 9357966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.